Home
Squadron Capital Management reported a 6.2% stake in Lipocine LPCN · 450,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.2%
- Last report
- 9.5% · filed 26/02/17
- Shares held
- 450,000 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- Lipocine LPCN
- Event date
- 26/03/31
- Filed
- 26/05/15
6.2% stake · −3.3pp from the last report
- Stake
- 6.2%
- Last report
- 9.5%
- Since last report
- −3.3pp
Lipocine trades, last 26 weeks
What else happened in Lipocine around then
Filed or reported within 30 days of the trade day · 03/01~04/30Squadron Capital Management's other 5% stake reports
- Squadron Capital Management
5% stakeTraws Pharma
5% stakeTraws Pharma
TRAW
0% stake
0 sh
0% stake
Filed 08/14
- Squadron Capital Management
5% stakeRelmada Therapeutics
5% stakeRelmada Therapeutics
RLMD
7% stake
7,350,000 sh
7% stake
Filed 08/14
- Squadron Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
1.6% stake
64,464 sh
1.6% stake
Filed 08/14
- Squadron Capital Management
5% stakeLipocine
5% stakeLipocine
LPCN
9.8% stake
810,000 sh
9.8% stake
Filed 08/14
- Squadron Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
6.9% stake
7,600,000 sh
6.9% stake
Filed 08/14
